<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01846234</url>
  </required_header>
  <id_info>
    <org_study_id>Salt</org_study_id>
    <secondary_id>Salt-1</secondary_id>
    <nct_id>NCT01846234</nct_id>
  </id_info>
  <brief_title>Sodium Intake in Multiple Sclerosis</brief_title>
  <acronym>SALT</acronym>
  <official_title>Effect of Sodium Intake in Multiple Sclerosis Disease Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, it has been shown that salt (ClNa, sodium chloride) can modulate the
      differentiation of human and mouse TH17 cells. Indeed, mice feed with high sodium diet were
      described to develop more aggressive course of EAE (Experimental Autoimmune Encephalitis).

      However, the role of sodium intake in MS has not been investigated. In this study we
      investigate the effect of sodium intake in Multiple Sclerosis (MS) clinical and radiological
      activity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Exacerbation rate</measure>
    <time_frame>2 years</time_frame>
    <description>Number of disease relapses during follow up time according to salt consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiological activity</measure>
    <time_frame>One year</time_frame>
    <description>Number of new lesions in MRI</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">132</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>MS patients</arm_group_label>
    <description>MS patients</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 70 patients with relapsing-remitting MS according to McDonald criteria1 were
        recruited from the MS clinic at FLENI by attending neurologists. A second group of 52
        relapsing-remitting MS patients was recluted later.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is between 18 and 50 years old

          -  Subject has diagnosis of relapsing-remitting MS according to McDonald criteria (2010)

        Exclusion Criteria:

          -  Patient who had hyponatremia in the last 90 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauricio F Farez, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>FLENI</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1428</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2013</study_first_submitted>
  <study_first_submitted_qc>May 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2013</study_first_posted>
  <last_update_submitted>October 21, 2013</last_update_submitted>
  <last_update_submitted_qc>October 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia</investigator_affiliation>
    <investigator_full_name>Mauricio F. Farez</investigator_full_name>
    <investigator_title>Research Associate</investigator_title>
  </responsible_party>
  <keyword>Multiple Sclerosis</keyword>
  <keyword>Salt</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

